Charles Schwab Investment Management Inc. Purchases 179,600 Shares of Envista Holdings Co. (NYSE:NVST)

Charles Schwab Investment Management Inc. increased its holdings in shares of Envista Holdings Co. (NYSE:NVST - Free Report) by 8.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,317,631 shares of the company's stock after purchasing an additional 179,600 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.35% of Envista worth $44,707,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in NVST. US Bancorp DE lifted its position in shares of Envista by 150.6% during the 3rd quarter. US Bancorp DE now owns 4,971 shares of the company's stock worth $98,000 after purchasing an additional 2,987 shares during the last quarter. Assetmark Inc. increased its stake in Envista by 5.9% during the third quarter. Assetmark Inc. now owns 38,641 shares of the company's stock valued at $764,000 after acquiring an additional 2,152 shares during the period. State of New Jersey Common Pension Fund D increased its stake in Envista by 5.4% during the third quarter. State of New Jersey Common Pension Fund D now owns 107,686 shares of the company's stock valued at $2,128,000 after acquiring an additional 5,497 shares during the period. Huntington National Bank increased its stake in Envista by 97.8% during the third quarter. Huntington National Bank now owns 1,919 shares of the company's stock valued at $38,000 after acquiring an additional 949 shares during the period. Finally, Royce & Associates LP increased its stake in Envista by 6.3% during the third quarter. Royce & Associates LP now owns 278,904 shares of the company's stock valued at $5,511,000 after acquiring an additional 16,547 shares during the period.

Remove Ads

Envista Trading Down 1.6 %

NYSE:NVST traded down $0.27 during trading hours on Tuesday, hitting $16.90. 2,093,753 shares of the stock were exchanged, compared to its average volume of 2,282,663. The company's 50 day moving average is $19.94 and its two-hundred day moving average is $19.64. Envista Holdings Co. has a twelve month low of $15.15 and a twelve month high of $23.00. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $2.91 billion, a P/E ratio of -2.60, a price-to-earnings-growth ratio of 1.27 and a beta of 1.33.

Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. On average, sell-side analysts anticipate that Envista Holdings Co. will post 1 earnings per share for the current fiscal year.

Analysts Set New Price Targets

NVST has been the topic of several research reports. Needham & Company LLC restated a "hold" rating on shares of Envista in a research note on Thursday, March 6th. Wells Fargo & Company set a $19.00 price objective on Envista in a research note on Saturday, March 8th. Mizuho started coverage on Envista in a research note on Wednesday, December 4th. They issued an "underperform" rating and a $20.00 price objective on the stock. Jefferies Financial Group upped their price objective on Envista from $20.00 to $22.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Finally, Morgan Stanley decreased their price target on Envista from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Thursday, March 6th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $20.18.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.